| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,554,000 | 4,370,000 | 4,370,000 | 4,533,000 | | Cost of Revenue | 2,104,000 | 2,642,000 | 2,581,000 | 2,595,000 | | | Gross Profit | 1,450,000 | 1,728,000 | 1,789,000 | 1,938,000 | | | Operating Expenses | | Research Development | 204,000 | 212,000 | 228,000 | 223,000 | | Selling General and Administrative | 1,031,000 | 1,883,000 | 1,103,000 | 1,205,000 | | Non Recurring | (2,000) | (467,000) | 36,000 | 41,000 | | Others | 14,000 | 54,000 | (26,000) | 26,000 | | | | Total Operating Expenses | 1,247,000 | 1,682,000 | 1,341,000 | 1,495,000 | | | | Operating Income or Loss | 203,000 | 46,000 | 448,000 | 443,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 18,000 | (64,000) | 80,000 | | Earnings Before Interest And Taxes | 208,000 | 64,000 | 384,000 | 523,000 | | Interest Expense | 130,000 | 143,000 | 146,000 | 278,000 | | Income Before Tax | 78,000 | (79,000) | 238,000 | 245,000 | | Income Tax Expense | 19,000 | (59,000) | 15,000 | 59,000 | | Minority Interest | (7,000) | (92,000) | 92,000 |
-
| | | | Net Income From Continuing Ops | 42,000 | 1,000 | 258,000 | 215,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,000 | 1,000 | 258,000 | 215,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,000 | $1,000 | $258,000 | $215,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
